[1] |
Ye R, Wang C, Zhao L, et al. Characteristics of miliary tuberculosis in pregnant women after in vitro fertilization and embryo transfer. Int J Tuberc Lung Dis, 2019,23(2):136-139. doi: 10.5588/ijtld.18.0223.
|
[2] |
段纯, 喻艳林. 妊娠合并结核病的研究进展. 中华传染病杂志, 2018,36(5):317-320. doi: 10.3760/cma.j.issn.1000-6680.2018.05.016.
|
[3] |
孙秀利, 任倍莹, 许军丽. 不同治疗时机对妊娠并发肺结核患者结局的影响. 中国防痨杂志, 2016,38(9):747-750. doi: 10.3969/j.issn.1000-6621.2016.09.011.
|
[4] |
Sugarman J, Colvin C, Moran AC, et al. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health, 2014,2(12):e710-716. doi: 10.1016/S2214-109X(14)70330-4.
|
[5] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断, 201711-09.
|
[6] |
中华医学会. 临床诊疗指南:结核病分册, 北京: 人民卫生出版社, 2005: 10-12.
|
[7] |
Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med, 1972,77(4):507-513. doi: 10.7326/0003-4819-77-4-507.
|
[8] |
乔玉环, 李留霞, 孙莹璞. 妇产科学, 北京: 人民军医出版社, 2006: 25-27.
|
[9] |
Wolf B, Krasselt de, de Fallois J, et al. Tuberculosis in pregnancy-a summary. Geburtshilfe Frauenheilkd, 2019,79(4):358-365. doi: 10.1055/a-0774-7924.
|
[10] |
Sobhy S, Babiker Z, Zamora J, et al. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis. BJOG, 2017,124(5):727-733. doi: 10.1111/1471-0528.14408.
|
[11] |
唐神结, 高文. 临床结核病学.2版. 北京: 人民卫生出版社, 2019: 786-792.
|
[12] |
宋斌, 卢水华. 预防结核病母婴传播的对策[J/OL]. 新发传染病电子杂志, 2017,2(3):138-142. doi: 10.3877/j.issn.2096-2738.2017.03.004.
|
[13] |
徐晓红, 滕红. 妊娠合并结核病的管理[J/OL]. 中华产科急救电子杂志, 2017,6(3):161-165. doi: 10.3877/cma.j.issn.2095-3259.2017.03.007.
|
[14] |
Nguyen HT, Pandolfini C, Chiodini P, et al. Tuberculosis care for pregnant women: a systematic review. BMC Infect Dis, 2014,14:617. doi: 10.1186/s12879-014-0617-x.
|
[15] |
黄凌佳, 杨舒奇, 韩杰霞, 等. 妊娠合并结核的相关研究进展. 中国生育健康杂志, 2019,30(1):91-93.doi: 10.3969/j.issn.1671-878x.2019.01.024.
|
[16] |
Asghar MU, Mehta SS, Cheema HA, et al. Sputum smear and culture-negative tuberculosis with associated pleural effusion: a diagnostic challenge. Cureus, 2018,10(10):e3513. doi: 10.7759/cureus.3513.
|
[17] |
Bielsa S, Acosta C, Pardina M, et al. Tuberculous pleural effusion: clinical characteristics of 320 patients. Arch Bronconeumol, 2019,55(1):17-22. doi: 10.1016/j.arbres.2018.04.014.
|
[18] |
杨新婷, 关国英, 王亚红, 等. 结核性胸膜炎的临床特征及诊断技术分析. 中国防痨杂志, 2017,39(11):1162-1168.doi: 10.3969/j.issn.1000-6621.2017.11.003.
|
[19] |
Jo T, Kuse N, Inomata M, et al. Efficacy and safety of semi-flexible thoracoscopic cryobiopsy in the diagnosis of elderly tuberculous pleurisy. Respir Med Case Rep, 2020,29:101008. doi: 10.1016/j.rmcr.2020.101008.
|
[20] |
黄毅, 杨翰, 冯璇, 等. 超声引导下获取标本行病理学与结核相关检测对结核性胸膜炎的诊断价值. 中国防痨杂志, 2019,41(8):833-837.doi: 10.3969/j.issn.1000-6621.2019.08.006.
|
[21] |
曹兵生, 张蕊, 张更臣, 等. 超声引导下胸膜活检诊断结核性胸膜炎影响因素分析. 中华老年多器官疾病杂志, 2016,15(7):516-518.doi: 10.11915/j.issn.1671-5403.2016.07.122.
|
[22] |
中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版). 北京: 中国协和医科大学出版社, 2009.
|
[23] |
周开元, 周红丽. 观察肾上腺皮质激素对结核性胸膜炎的临床疗效. 中国社区医师, 2019,35(15):81-83.doi: 10.3969/j.issn.1007-614x.2019.15.056.
|
[24] |
Sun F, Li L, Liao X, et al. Adjunctive use of prednisolone in the treatment of free-flowing tuberculous pleural effusion: A retro-spective cohort study. Respir Med, 2018,139:86-90. doi: 10.1016/j.rmed.2018.05.002.
|
[25] |
Xie S, Lu L, Li M, et al. The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisy: a systematic review and meta-analysis. Oncotarget, 2017,8(47):83315-83322. doi: 10.18632/oncotarget.18160.
|
[26] |
Ryan H, Yoo J, Darsini P, et al. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev, 2017,3:CD001876. doi: 10.1002/14651858.CD001876.pub3.
|
[27] |
吴华, 章友康. 妊娠及哺乳期女性糖皮质激素和免疫抑制剂的合理应用[J/OL]. 中华肾脏研究电子杂志, 2018,7(6):241-244.doi: 10.3877/cma.j.issn.2095-3216.2018.06.001.
|